ArticleMolecular therapy. Advances2026

Low dose systemic AAV-exendin-4 gene therapy for Prader-Willi syndrome and dietary obesity.

Wei Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.